Groups Endorse Shorter RT for Prostate Cancer

13:45 EDT 11 Oct 2018 | MedPageToday

(MedPage Today) -- Similar cancer outcomes, overall toxicity with hypofractionated, standard RT

Original Article: Groups Endorse Shorter RT for Prostate Cancer

More From BioPortfolio on "Groups Endorse Shorter RT for Prostate Cancer"